Literature DB >> 2089137

Amyotrophic lateral sclerosis: unusually low content of collagen in skin.

S Ono1, G L Mechanic, M Yamauchi.   

Abstract

The skin tissues from patients with amyotrophic lateral sclerosis (ALS) and controls were studied by electron microscopy, and their amino acid compositions were examined. On electron microscopy, the most conspicuous findings in ALS were (1) a marked increase in amorphous material separating collagen bundles, and (2) the smaller diameter of collagen fibrils. These were more marked with longer duration of illness. Amino acid analysis showed that the levels of hydroxyproline, hydroxylysine, and glycine were significantly low (P less than 0.001, P less than 0.01, and P less than 0.001, respectively) in ALS patients as compared with those of controls, and there was a significant negative correlation between the level of hydroxyproline and duration of illness in ALS patients (r = -0.88, P less than 0.01). In addition, the collagen content per dry weight (mg) of the tissues in ALS was significantly smaller (P less than 0.001) than in controls. These results indicate that the metabolism of skin collagen might be affected in the disease process of ALS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089137     DOI: 10.1016/0022-510x(90)90038-o

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis.

Authors:  S Ono; J Hu; T Imai; N Shimizu; M Tsumura; H Nakagawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

2.  Elastin cross-linking in the skin from patients with amyotrophic lateral sclerosis.

Authors:  S Ono; M Yamauchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

3.  Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity.

Authors:  Alice Brockington; Ke Ning; Paul R Heath; Elizabeth Wood; Janine Kirby; Nicolò Fusi; Neil Lawrence; Stephen B Wharton; Paul G Ince; Pamela J Shaw
Journal:  Acta Neuropathol       Date:  2012-11-13       Impact factor: 17.088

Review 4.  Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach.

Authors:  Alok Kumar; Devlina Ghosh; R L Singh
Journal:  J Biomark       Date:  2013-03-14

5.  GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis.

Authors:  William R Swindell; Krzysztof Bojanowski; Mark S Kindy; Raymond M W Chau; Dorothy Ko
Journal:  Transl Neurodegener       Date:  2018-12-03       Impact factor: 8.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.